Related Experiment Video
Updated: Oct 13, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Targeting long non coding RNA by natural products: Implications for cancer therapy
Mina Homayoonfal1, Zatollah Asemi1, Bahman Yousefi2,3
1Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, I.R. Iran.
Abstract:
In spite of achieving substantial progress in its therapeutic strategies, cancer-associated prevalence and mortality are persistently rising globally. However, most malignant cancers either cannot be adequately diagnosed at the primary phase or resist against multiple treatments such as chemotherapy, surgery, radiotherapy as well as targeting therapy. In recent decades, overwhelming evidences have provided more convincing words on the undeniable roles of long non-coding RNAs (lncRNAs) in incidence and development of various cancer types. Recently, phytochemical and nutraceutical compounds have received a great deal of attention due to their inhibitory and stimulatory effects on oncogenic and tumor suppressor lncRNAs respectively that finally may lead to attenuate various processes of cancer cells such as growth, proliferation, metastasis and invasion. Therefore, application of phytochemicals with anticancer characteristics can be considered as an innovative approach for treating cancer and increasing the sensitivity of cancer cells to standard prevailing therapies. The purpose of this review was to investigate the effect of various phytochemicals on regulation of lncRNAs in different human cancer and evaluate their capabilities for cancer treatment and prevention.
Insights
Phytochemicals can regulate long non-coding RNAs (lncRNAs), offering a novel approach to combat cancer. This review explores their potential in cancer treatment and prevention by modulating lncRNA activity.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Cancer incidence and mortality continue to rise globally despite therapeutic advancements.
- Many cancers are diagnosed late or develop resistance to conventional treatments like chemotherapy and radiotherapy.
- Long non-coding RNAs (lncRNAs) play crucial roles in cancer development and progression.
Approach:
- This review investigates the impact of various phytochemicals on lncRNA regulation in human cancers.
- It evaluates the potential of phytochemicals to inhibit oncogenic lncRNAs and stimulate tumor suppressor lncRNAs.
- The study assesses phytochemicals as an innovative strategy to enhance cancer treatment and prevention.
Key Points:
- Phytochemicals demonstrate inhibitory effects on oncogenic lncRNAs, crucial for cancer cell growth, proliferation, metastasis, and invasion.
- Certain phytochemicals can stimulate tumor suppressor lncRNAs, counteracting cancer development.
- Phytochemicals may increase cancer cell sensitivity to standard therapies.
Conclusions:
- Phytochemicals represent a promising avenue for cancer therapy and prevention by targeting lncRNA pathways.
- Further research into phytochemical-lncRNA interactions could lead to novel, effective cancer treatment strategies.
- Integrating phytochemicals with existing therapies may improve patient outcomes and overcome treatment resistance.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Targeted Cancer Therapies
There are several types of targeted therapies against...
Types of RNA
RNA Performs Diverse...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
MicroRNAs
Experimental RNAi

